Company: BSAAR
Filing Date: 2025-03-28
Form Type: S-1
Source: 0001013762-25-004269
Chunk: 80

Company: BEST SPAC I Acquisition Corp.
Filing Date: 2025-03-28
Form: S-1
Chunk 80
---
 issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion of the Class B shares at the time of the initial business combination, or earlier at the option of the holders, as described herein and in our amended and restated memorandum and articles of association. The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital structure. Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by any pandemic outbreaks and the status of debt and equity markets. Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by any pandemic outbreaks and the status of debt and equity markets. A significant pandemic of infectious diseases could result in a widespread health crisis that could adversely 46 affect the economies and financial markets worldwide, and the business of any potential target business with which we consummate a business combination could be materially and adversely affected by such pandemic. Furthermore, we may be unable to complete a business combination if concerns relating to any pandemic restrict travel, limit the ability to have meetings with potential investors or result in the target company’s personnel, vendors and services providers being unavailable to negotiate and consummate a transaction in a timely manner. The extent to which a pandemic impacts our search for a business combination will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of such pandemic and the actions to contain such pandemic or treat its impact, among others. If the disruptions posed by a pandemic outbreak or other matters of global concern continue for an extended period of time, our ability to consummate a business combination, or the operations of a target business with which we ultimately consummate a business combination, may be materially adversely affected. In addition, our ability to consummate a transaction may be dependent on our ability to raise equity and debt financing which may be adversely impacted by the outbreak of a pandemic or other events, including as a result of increased market volatility, decreased market liquidity and third -partyfinancing being unavailable on terms acceptable to us or at all. We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may only receive $10.00 per share, or less than such amount in certain circumstances, and our rights